Plain-English translation of NCT06813534 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to perform heart procedures (called coronary angioplasty) in patients with severe kidney disease. Instead of using contrast dye—which can damage kidneys—doctors will use ultrasound imaging to guide the procedure. The study wants to see if this approach prevents kidney damage that normally occurs in about 1 in 4 patients with severe kidney disease who receive standard heart procedures.
When patients with severe kidney disease receive heart procedures, the contrast dye used during imaging often causes additional kidney damage or even kidney failure. There is no cure for this damage once it happens, so this trial exists to test whether ultrasound guidance can prevent this complication and protect kidney health.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to one of two groups: the standard procedure group (using contrast dye as usual) or the ultrasound-guided group (using ultrasound imaging with minimal or no contrast dye). You will receive your heart procedure as planned, and doctors will monitor your kidney function with blood tests for 72 hours after the procedure to see whether kidney damage occurred. The study will compare kidney health outcomes between the two groups.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
France